7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies
7-hydroxy-2-N,N-dipropylaminotetralin: RN given refers to cpd without isomeric designation
Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papp, M | 1 |
| Gruca, P | 1 |
| Lason, M | 1 |
| Niemczyk, M | 1 |
| Willner, P | 1 |
1 other study available for 7-hydroxy-2-n,n-dipropylaminotetralin and Depressive Disorder, Treatment-Resistant
| Article | Year |
|---|---|
The role of prefrontal cortex dopamine D2 and D3 receptors in the mechanism of action of venlafaxine and deep brain stimulation in animal models of treatment-responsive and treatment-resistant depression.
Topics: Animals; Behavior, Animal; Deep Brain Stimulation; Depression; Depressive Disorder, Treatment-Resist | 2019 |